Screening for Prostate Cancer Starting at Age 50–54 Years. A Population-based Cohort Study

Current prostate cancer screening guidelines conflict with respect to the age at which to initiate screening.To evaluate the effect of prostate-specific antigen (PSA) screening versus zero screening, starting at age 50-54 yr, on prostate cancer mortality.This is a population-based cohort study comparing 3479 men aged 50 yr through 54 yr randomized to PSA-screening in the Göteborg population-based prostate cancer screening trial, initiated in...